AU Stock MarketDetailed Quotes

MYX Mayne Pharma Group Ltd

Watchlist
  • 4.780
  • +0.110+2.36%
20min DelayMarket Closed Dec 27 16:00 AET
388.36MMarket Cap-2.18P/E (Static)

Mayne Pharma Group Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mayne Pharma Group Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 218.600M--
--2025/H1-- / 203.200M--
Feb 26, 20242024/H1187.926M / ----
Aug 31, 20232023/H282.421M / 160.900M--
Aug 26, 20222022/H2228.362M / 209.450M--
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 218.600M--
--2025/H1-- / 203.200M--
Feb 26, 20242024/H1187.926M / ----
Aug 31, 20232023/H282.421M / 160.900M--
Aug 26, 20222022/H2228.362M / 209.450M--

Unlock Free Earnings Estimates

Mayne Pharma Group Ltd Earnings Reports

  • Mayne Pharma Group Ltd: Annual Report to shareholders

    Oct 17 17:33 ET

  • Mayne Pharma Group Ltd: 2024 Full Year Results Investor Presentation

    Aug 22 18:48 ET

  • Mayne Pharma Group Ltd: 2024 Full Year Results Media Release

    Aug 22 18:47 ET

  • Mayne Pharma Group Ltd: Appendix 4E and Full Year Statutory Accounts

    Aug 22 18:44 ET

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Westpac Banking Corp
    WBC
    +0.71%
    CommBank
    CBA
    +0.70%
    Fortescue Ltd
    FMG
    +0.65%
    Rio Tinto Ltd
    RIO
    +0.58%
    National Australia Bank Ltd
    NAB
    +0.51%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 2, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data